Glaucoma Clinical Trial
— ADAPT-LAHOfficial title:
Living Successfully With Chronic Eye Diseases: the 'Living Successfully With Low Vision' (LSLV) Program - a Randomized Controlled Trial of a Self-management Program for Low Vision
The need for low vision services (LVS) will increase exponentially over the coming years due
to the anticipated and exponential growth in the ageing population in Singapore and a rise
in chronic non-communicable eye diseases. Finding the best evidenced-based management for
chronic eye diseases contributing to low vision (LV) is therefore crucial. Improving patient
responsibility is the key to managing LV effectively.1 This means achieving optimum self
management (SM).2 However, there are currently no LV SM programs in Singapore and none has
been evaluated using a randomized controlled trial (RCT) design, the gold standard methods
to evaluate health interventions.
The aims of this study are to assess the effectiveness of the 'Living Successfully with Low
Vision (LSLV)' program in improving quality of life (QoL) in 160 elderly people with LV
attending the Singapore National Eye Centre (SNEC) LV clinic. Of these, 80 will be randomly
allocated to receive the LSLV 4-week SM program while the remaining 80 will receive the
usual care. Comparisons will be made to determine the efficacy of the LSLV program. QoL,
self-efficacy, emotional well being, and vision-specific distress will be assessed 2 weeks
after training, and at six months and 12 months post intervention.
This study will be the first evidenced-based RCT investigating the effectiveness of a novel
vision-specific self-management strategy to improve QoL. It will also adopt a longitudinal
design where the effectiveness of these interventions will be evaluated at 12 months-the
first follow-up assessment of that duration at both national and international levels.
Furthermore this will be the first study to characterize and profile the patients where the
effect of the program did not demonstrate an improvement in both primary and secondary
outcomes six months after its completion. The future clinical implications of this study
include the potential to implement a successful model of LV rehabilitation in other tertiary
centres around the country.
Status | Recruiting |
Enrollment | 160 |
Est. completion date | January 2015 |
Est. primary completion date | January 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 45 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Age 45 years to 75 years - Visual acuity =6/12 to =6/480 in the better eye after best correction OR - Visual field of less than 10 degrees from the point of fixation, but with the potential to use vision for the planning and/or execution of a task - Duration of low vision = 2 years - No cognitive impairment (as assessed with the 6-item cognitive impairment test) - Have adequate hearing with/without aids to respond to normal conversation Exclusion Criteria: - Not matching the above |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
Singapore | Singapore National Eye Centre | Singapore |
Lead Sponsor | Collaborator |
---|---|
Singapore Eye Research Institute | Curtin University of Technology, Ministry of Health, Singapore, Singapore National Eye Centre, University of Melbourne |
Singapore,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Vision-related quality of life | up to 12 months post intervention | No | |
Secondary | Perceived self-efficacy, emotional well being, and vision-specific distress | baseline (before randomization to either usual care or intervention group); 2 weeks, 6 months and 12 months post intervention | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Completed |
NCT02246764 -
Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
|
Phase 3 | |
Completed |
NCT02520674 -
Glaucoma Screening With Smartphone Ophthalmology
|
N/A | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A |